Your browser doesn't support javascript.
loading
Primary intracranial neuroendocrine tumor: two case reports.
Liu, Hailong; Wang, Haoran; Qi, Xueling; Yu, Chunjiang.
Afiliação
  • Liu H; Department of Neurosurgery, Sanbo Brain Hospital Capital Medical University, No. 50 Xiang Shan Yi-Ke-Song, Haidian District, Beijing, 100093, People's Republic of China.
  • Wang H; Department of Neurosurgery, Sanbo Brain Hospital Capital Medical University, No. 50 Xiang Shan Yi-Ke-Song, Haidian District, Beijing, 100093, People's Republic of China.
  • Qi X; Department of Neurosurgery, Sanbo Brain Hospital Capital Medical University, No. 50 Xiang Shan Yi-Ke-Song, Haidian District, Beijing, 100093, People's Republic of China.
  • Yu C; Department of Neurosurgery, Sanbo Brain Hospital Capital Medical University, No. 50 Xiang Shan Yi-Ke-Song, Haidian District, Beijing, 100093, People's Republic of China. liuhailonger@163.com.
World J Surg Oncol ; 14: 138, 2016 Apr 30.
Article em En | MEDLINE | ID: mdl-27138163
BACKGROUND: Neuroendocrine tumor originates from the diffuse neuroendocrine system. Intracranial originating is lower to 0.74 %. CASE PRESENTATION: We present two cases of primary intracranial neuroendocrine tumor A 39-year-old woman was admitted with headache, fever, polydipsia and polyuria. Biochemical and endocrinological results showed hyponatremia, hypothyroidism and hypopituitarism. MRI scans demonstrated an obviouslyenhancing lesion in seller and superseller area. Then a gross removal of tumor was achieved during the single nostril transsphenoidal approach surgery. Pathological diagnosis was high-grade small-cell neuroendocrine tumor. A 40-year-old woman presented with multiple symptoms and neurological deficit. Neuroimaging results demonstrated a huge obviously-enhancing tumor in anterior cranial fossa. Biochemical and hormone findings revealed hypokalemia, high glucose and hypercortisolemia. The intracranial surgery achieved a gross removal through a right frontal craniotomy. Pathological diagnosis was low-grade small-cell neuroendocrine tumor with immuno-negativity for ACTH. CONCLUSION: The mechanism, diagnosis, and treatment of neuroendocrine tumor are still challenging.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Tumores Neuroendócrinos / Carcinoma de Células Pequenas Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Tumores Neuroendócrinos / Carcinoma de Células Pequenas Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article